Severe hypoglycemia caused 4 hospital-grade seizures or loss-of-consciousness events out of 71 patients in the Increlex program it is not a theoretical risk
I mean, I like I sometimes let myself on Twitter, you know, you know, a new study comes out in somebody like, look at the power of this medication
While the 2025 Employer Health Benefit Survey finds there was a notable increase in the share of the largest firms (5,000+) that cover GLP-1 medications for weight loss, the conversations with employers highlight their concerns about the cost of these medications
If patient cannot tolerate 3 mg dose, 2.4 mg dose may be used
Retatrutides substantial fat loss over 48 weeks may produce some loose skin in individuals losing 50+ lbs, similar to any approach achieving comparable results